KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Debt Ratio: 2011-2022

Historic Debt Ratio for TherapeuticsMD (TXMD) over the last 6 years, with Sep 2022 value amounting to 0.70.

  • TherapeuticsMD's Debt Ratio fell 21.53% to 0.70 in Q3 2022 from the same period last year, while for Sep 2022 it was 4.30, marking a year-over-year increase of 5.69%. This contributed to the annual value of 1.11 for FY2021, which is 15.12% down from last year.
  • According to the latest figures from Q3 2022, TherapeuticsMD's Debt Ratio is 0.70, which was up 12.58% from 0.62 recorded in Q2 2022.
  • Over the past 5 years, TherapeuticsMD's Debt Ratio peaked at 1.52 during Q1 2022, and registered a low of 0.31 during Q3 2018.
  • In the last 3 years, TherapeuticsMD's Debt Ratio had a median value of 0.90 in 2020 and averaged 1.00.
  • Its Debt Ratio has fluctuated over the past 5 years, first surged by 151.28% in 2019, then tumbled by 33.38% in 2021.
  • Over the past 5 years, TherapeuticsMD's Debt Ratio (Quarterly) stood at 0.35 in 2018, then spiked by 111.39% to 0.73 in 2019, then soared by 78.86% to 1.31 in 2020, then decreased by 15.12% to 1.11 in 2021, then fell by 21.53% to 0.70 in 2022.
  • Its Debt Ratio was 0.70 in Q3 2022, compared to 0.62 in Q2 2022 and 1.52 in Q1 2022.